- Home
- INTU vs GSK Comparison
INTU vs GSK Comparison
Compare INTU & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INTU | GSK |
|---|---|---|
| Founded | 1983 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | 66841 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.4B | 108.7B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | INTU | GSK |
|---|---|---|
| Price | $407.17 | $50.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 2 |
| Target Price | ★ $692.35 | N/A |
| AVG Volume (30 Days) | 3.0M | ★ 4.0M |
| Earning Date | 05-21-2026 | 04-29-2026 |
| Dividend Yield | 1.22% | ★ 3.40% |
| EPS Growth | ★ 31.06 | N/A |
| EPS | ★ 4.06 | N/A |
| Revenue | ★ $18,831,000,000.00 | N/A |
| Revenue This Year | $15.03 | $6.99 |
| Revenue Next Year | $12.41 | $4.19 |
| P/E Ratio | $98.33 | ★ $32.75 |
| Revenue Growth | ★ 15.63 | N/A |
| 52 Week Low | $342.11 | $35.45 |
| 52 Week High | $813.48 | $61.70 |
Technical Indicators
Market Signals| Indicator | INTU | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 51.76 | 31.77 |
| Support Level | $345.55 | $47.89 |
| Resistance Level | $419.00 | $51.46 |
| Average True Range (ATR) | 14.21 | 0.96 |
| MACD | 3.29 | -0.70 |
| Stochastic Oscillator | 74.85 | 9.51 |
Price Performance
Historical ComparisonAbout INTU Intuit Inc.
Intuit serves small and midsize businesses with accounting software QuickBooks and online marketing platform Mailchimp. The company also operates retail tax filing tool TurboTax, personal finance platform Credit Karma, and a suite of professional tax offerings for accountants. Founded in the mid-1980s, Intuit enjoys a dominant market share for small-to-midsize business accounting and self-serve tax filing in the US.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.